GlassScriptPhysician profile
Daniel D Billings
NPI 1639539539
$3,042.27
in general payments reported to CMS, 2019-2025
19 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 88% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $162 · 2023: $727 · 2024: $834 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,560 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.18 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $779.55 | 2023-2025 | Opdivo |
| Novartis Pharmaceuticals Corporation | $634.62 | 2022-2025 | |
| Janssen Biotech, INC. | $240.10 | 2024-2025 | Tecvayli, Darzalex, Talvey |
| Pharmaessentia USA Corporation | $207.71 | 2025 | Besremi |
| Astellas Pharma US INC | $158.20 | 2023-2024 | Xospata |
| Apellis Pharmaceuticals, INC. | $157.65 | 2024-2025 | Empaveli |
| Agios Pharmaceuticals, INC. | $124.97 | 2025 | Pyrukynd |
| Global Blood Therapeutics, INC. | $121.68 | 2022 | |
| Dova Pharmaceuticals | $120.94 | 2021 | |
| Alexion Pharmaceuticals, INC. | $118.73 | 2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $112.74 | 2023 | Libtayo |
| Exelixis INC. | $99.00 | 2023 | |
| Daiichi Sankyo INC. | $28.25 | 2025 | Vanflyta |
| Celgene Corporation | $26.98 | 2023 | |
| Cti Biopharma Corp. | $24.93 | 2023 | Vonjo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.41 | 2024 | |
| Pfizer INC. | $23.20 | 2023 | |
| Incyte Corporation | $22.78 | 2023 | Jakafi |
| Sobi, INC | $16.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Billings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.